Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application.

[1]  T. Nagai,et al.  Influence of non-ionic surfactants, pH and propylene glycol on percutaneous absorption of piroxicam from cataplasm. , 1999, International journal of pharmaceutics.

[2]  A. Urtti,et al.  Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[3]  S. Fukushima,et al.  Enhancement of propylene glycol distribution in the skin by high purity cis-unsaturated fatty acids with different alkyl chain lengths having different double bond position. , 1999, Biological & pharmaceutical bulletin.

[4]  C. Cho,et al.  Permeation of piroxicam from the poloxamer gels. , 1999, Drug development and industrial pharmacy.

[5]  S. Fukushima,et al.  Skin Penetration Enhancing Action of cis-Unsaturated Fatty Acids with ω-9, and ω-12-Chain Lengths , 1998 .

[6]  K. Bhatia,et al.  Synergistic effect of iontophoresis and a series of fatty acids on LHRH permeability through porcine skin. , 1998, Journal of pharmaceutical sciences.

[7]  S. Jeong,et al.  Enhanced transdermal delivery of AZT (Zidovudine) using iontophoresis and penetration enhancer. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[8]  F. Plakogiannis,et al.  Evaluation of the effect of different fatty acids on the percutaneous absorption of metaproterenol sulfate. , 1996, Journal of pharmaceutical sciences.

[9]  Howard I. Maibach,et al.  Evaluation of the Barrier Function of Skin Using Transepidermal Water Loss (TEWL): A Critical Overview , 2014 .

[10]  A. Kaneko,et al.  Accumulation of lauric acid in skin as an enhancer for the percutaneous absorption of thiamine disulfide. , 1995, Biological & pharmaceutical bulletin.

[11]  S. Santoyo,et al.  Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin , 1995 .

[12]  S. Fukushima,et al.  Behavior of propylene glycol (PG) in dermis after treatment of rat intact skin surface with fatty acids, fatty amines or azone dissolved in PG. , 1995, Biological & pharmaceutical bulletin.

[13]  Hsu Li-Ren,et al.  Percutaneous absorption of piroxicam from FAPG base through rat skin : effects of fatty acid added to FAPG base , 1994 .

[14]  P. Dykes,et al.  Plasma and cutaneous drug levels after topical application of piroxicam gel: a study in healthy volunteers. , 1994, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[15]  M. Roberts,et al.  Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. , 1994, The Journal of pharmacology and experimental therapeutics.

[16]  T. Uchida,et al.  Skin permeation enhancement of tegafur by ethanol/panasate 800 or ethanol/water binary vehicle and combined effect of fatty acids and fatty alcohols. , 1993, Journal of pharmaceutical sciences.

[17]  B. W. Barry.  Lipid-Protein-Partitioning theory of skin penetration enhancement , 1991 .

[18]  J. Hadgraft,et al.  Oleic acid — a membrane “fluidiser” or fluid within the membrane? , 1991 .

[19]  F. Plakogiannis,et al.  Piroxicam Release from Dermatological Base: In-Vitro Studies using Cellulose Membrane and Hairless Mouse Skin , 1990 .

[20]  R. Guy,et al.  In vitro and in vivo enhancement of skin permeation with oleic and lauric acids , 1988 .

[21]  R O Potts,et al.  Role of stratum corneum lipid fluidity in transdermal drug flux. , 1987, Journal of pharmaceutical sciences.

[22]  Naito Shun-Ichi,et al.  Percutaneous absorption of piroxicam from ointment bases in rabbits , 1985 .